GlassScriptPhysician profile
Katia Del Valle
NPI 1689205973
$5,776.29
in general payments reported to CMS, 2019-2025
22 companies · $1,871 in 2025
The $1,871 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $299 · 2022: $1,434 · 2023: $1,353 · 2024: $819 · 2025: $1,871.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,651 · Travel and Lodging: $392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,650.71 |
| Travel and Lodging | $392.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,037.22 | 2022 | |
| Teleflex LLC | $788.78 | 2022-2025 | Urolift, Barrigel |
| Coloplast Corp | $598.68 | 2024-2025 | |
| Procept Biorobotics Corporation | $582.55 | 2024-2025 | Aquabeam System |
| Janssen Biotech, INC. | $490.87 | 2023-2025 | Rybrevant, Carvykti, Erleada |
| Merck Sharp & Dohme LLC | $353.56 | 2023 | Keytruda, Lynparza, Welireg |
| Antares Pharma, INC. | $227.00 | 2022-2023 | Tlando, Nocdurna, Xyosted |
| Myriad Genetic Laboratories, INC. | $213.85 | 2022-2025 | Prolaris |
| Endo Pharmaceuticals INC. | $187.67 | 2021-2024 | Xiaflex, Aveed |
| Endo USA, INC. | $156.30 | 2024-2025 | Xiaflex |
| Astellas Pharma US INC | $145.84 | 2021-2023 | Myrbetriq |
| Boston Scientific Corporation | $136.79 | 2022 | |
| Sumitomo Pharma America, INC. | $133.61 | 2023-2024 | Orgovyx |
| Medtronic, INC. | $122.11 | 2025 | Interstim |
| 180 Medical, INC. | $113.91 | 2022-2024 | Gentlecath |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $104.87 | 2023 | |
| Urogen Pharma, INC. | $101.04 | 2023-2024 | Jelmyto |
| Abbvie INC. | $89.84 | 2023 | |
| Pfizer INC. | $84.99 | 2021 | |
| Abc Home Medical Supply, INC. | $45.15 | 2023 | |
| C. R. Bard, INC. & Subsidiaries | $43.68 | 2023 | Bard Urinary Drainage Bag |
| Convatec INC. | $17.98 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katia Del Valle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.